中基健康(000972) - 2018 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2018 was ¥47,328,180.62, representing a decrease of 31.30% compared to ¥68,892,620.64 in the same period last year[8] - The net profit attributable to shareholders was -¥9,981,246.45, an improvement from -¥20,725,628.91 year-on-year[8] - The net cash flow from operating activities decreased by 61.35% to ¥6,407,367.83 from ¥16,578,893.39 in the previous year[8] - Operating revenue fell by 31.30% to ¥47,328,180.62, primarily due to a decline in sales volume of large-pack tomato sauce[16] - Operating costs decreased by 48.52% to ¥33,007,693.23, reflecting the drop in sales volume of large-pack tomato sauce[16] Assets and Shareholder Information - The total assets at the end of the reporting period were ¥2,337,542,096.39, down 4.41% from ¥2,445,329,852.45 at the end of the previous year[8] - The net assets attributable to shareholders decreased by 1.20% to ¥871,791,318.16 from ¥882,362,014.79 at the end of the previous year[8] - The total number of ordinary shareholders at the end of the reporting period was 47,386[11] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., held 15.46% of shares, totaling 119,243,804 shares[11] Cash Flow and Expenses - Cash and cash equivalents decreased by 42.71% to ¥70,896,003.65 due to repayment of loans and accounts payable[16] - Accounts payable decreased by 36.27% to ¥247,745,818.82 as a result of repayment of payables[16] - Financial expenses increased by 51.36% to ¥11,427,856.76, attributed to exchange rate fluctuations and increased borrowing costs[16] - Cash received from tax refunds rose by 39.53% to ¥13,171,869.85, driven by an increase in export tax rebates[16] - Cash paid for purchasing goods and services increased by 33.46% to ¥168,644,399.21 due to higher accounts payable payments[16] - Cash paid for debt repayment increased by 96.96% to ¥100,000,000.00, reflecting a rise in matured loans compared to the previous year[16] Non-Recurring Items and Strategic Changes - The company reported a total of ¥353,574.80 in non-recurring gains and losses during the reporting period[9] - There were no significant changes in the company's strategy or new product developments mentioned in the report[15] - The company did not report any significant events or changes in commitments during the reporting period[17][18] - There were no derivative investments during the reporting period[22] Return on Net Assets - The weighted average return on net assets improved to -1.14%, up by 1.38 percentage points from -2.52% year-on-year[8]